193 related articles for article (PubMed ID: 22472774)
1. Neuroimmune semaphorin 4A downregulates the severity of allergic response.
Nkyimbeng-Takwi EH; Shanks K; Smith E; Iyer A; Lipsky MM; Detolla LJ; Kikutani H; Keegan AD; Chapoval SP
Mucosal Immunol; 2012 Jul; 5(4):409-19. PubMed ID: 22472774
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation.
Shanks K; Nkyimbeng-Takwi EH; Smith E; Lipsky MM; DeTolla LJ; Scott DW; Keegan AD; Chapoval SP
Mol Immunol; 2013 Dec; 56(4):480-7. PubMed ID: 23911404
[TBL] [Abstract][Full Text] [Related]
3. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.
Smith EP; Shanks K; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
BMC Immunol; 2011 May; 12():30. PubMed ID: 21595947
[TBL] [Abstract][Full Text] [Related]
4. An inhibitory role for Sema4A in antigen-specific allergic asthma.
Morihana T; Goya S; Mizui M; Yasui T; Prasad DV; Kumanogoh A; Tamura M; Shikina T; Maeda Y; Iwamoto Y; Inohara H; Kikutani H
J Clin Immunol; 2013 Jan; 33(1):200-9. PubMed ID: 23007237
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmune semaphorin 4A as a drug and drug target for asthma.
Mogie G; Shanks K; Nkyimbeng-Takwi EH; Smith E; Davila E; Lipsky MM; DeTolla LJ; Keegan AD; Chapoval SP
Int Immunopharmacol; 2013 Nov; 17(3):568-75. PubMed ID: 23994348
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1.
Chapoval SP; Hritzo M; Qi X; Tamagnone L; Golding A; Keegan AD
Immunohorizons; 2019 Feb; 3(2):71-87. PubMed ID: 31236543
[TBL] [Abstract][Full Text] [Related]
7. STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease.
Chapoval SP; Dasgupta P; Smith EP; DeTolla LJ; Lipsky MM; Kelly-Welch AE; Keegan AD
J Immunol; 2011 Feb; 186(4):2571-83. PubMed ID: 21242523
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-4 receptor α-positive CD4(+) T cells in chronic airway hyperresponsiveness.
Kirstein F; Nieuwenhuizen NE; Jayakumar J; Horsnell WGC; Brombacher F
J Allergy Clin Immunol; 2016 Jun; 137(6):1852-1862.e9. PubMed ID: 26688514
[TBL] [Abstract][Full Text] [Related]
9. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma.
Böhm L; Maxeiner J; Meyer-Martin H; Reuter S; Finotto S; Klein M; Schild H; Schmitt E; Bopp T; Taube C
J Immunol; 2015 Feb; 194(3):887-97. PubMed ID: 25527785
[TBL] [Abstract][Full Text] [Related]
10. Identifying Function Determining Residues in Neuroimmune Semaphorin 4A.
Chapoval SP; Lee M; Lemmer A; Ajayi O; Qi X; Neuwald AF; Keegan AD
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328445
[TBL] [Abstract][Full Text] [Related]
11. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab ameliorates OVA-induced airway inflammation in mice: Role of CD4(+) CD25(+) FOXP3(+) regulatory T-cells.
Elsakkar MG; Sharaki OA; Abdallah DM; Mostafa DK; Shekondali FT
Eur J Pharmacol; 2016 Sep; 786():100-108. PubMed ID: 27262379
[TBL] [Abstract][Full Text] [Related]
13. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.
He R; Kim HY; Yoon J; Oyoshi MK; MacGinnitie A; Goya S; Freyschmidt EJ; Bryce P; McKenzie AN; Umetsu DT; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2009 Oct; 124(4):761-70.e1. PubMed ID: 19815118
[TBL] [Abstract][Full Text] [Related]
14. Airway inflammation driven by antigen-specific resident lung CD4(+) T cells in alphabeta-T cell receptor transgenic mice.
Knott PG; Gater PR; Bertrand CP
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1340-8. PubMed ID: 10764332
[TBL] [Abstract][Full Text] [Related]
15. Foxp3(+)-Treg cells enhanced by repeated low-dose gamma-irradiation attenuate ovalbumin-induced allergic asthma in mice.
Park BS; Hong GU; Ro JY
Radiat Res; 2013 May; 179(5):570-83. PubMed ID: 23560633
[TBL] [Abstract][Full Text] [Related]
16. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse.
Shen HH; Ochkur SI; McGarry MP; Crosby JR; Hines EM; Borchers MT; Wang H; Biechelle TL; O'Neill KR; Ansay TL; Colbert DC; Cormier SA; Justice JP; Lee NA; Lee JJ
J Immunol; 2003 Mar; 170(6):3296-305. PubMed ID: 12626589
[TBL] [Abstract][Full Text] [Related]
17. Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice.
Nath P; Leung SY; Williams AS; Noble A; Xie S; McKenzie AN; Chung KF
Clin Exp Allergy; 2007 Oct; 37(10):1427-35. PubMed ID: 17883722
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells.
Burchell JT; Wikstrom ME; Stumbles PA; Sly PD; Turner DJ
Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L307-19. PubMed ID: 19028981
[TBL] [Abstract][Full Text] [Related]
19. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
20. IL-4Rα signaling in CD4+CD25+FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33.
Khumalo J; Kirstein F; Hadebe S; Brombacher F
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32931477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
